No epidemiological typing system to differentiate among Pseudomonas pseudomaklei isolates has been available. Ribotype analysis was developed and used to examine 74 clinical and 10 environmental isolates of P. pseudomaUlei from Thailand. Six P. pseudomaUei ribotypes were identified from restriction fragment polymorphisms ofEcoRl chromosomal digests. The predominant ribotype, A, was found in 59 of the isolates examined. By using patterns from hybridizations with SailI, HindIII, and PstI restriction digests, isolates of ribotype A were subdivided into a further five subtypes, giving a total of 10 differentiable P. pseudomallei types. In 23 of 34 melioidosis patients studied, multiple P. pseudomallei isolates were present. In all but one of these patients, a single ribotype of the organism was present. Isolation of two different ribotypes of P. pseudomallei from one patient, one each in sputum and urine, suggests that superinfection may have occurred. The ribotype was shown to be conserved during the course of antibiotic treatments in seven patients studied, although the antibiotic sensitivity patterns in the isolates from these patients varied. The prevalence of subtype Al in clinical and environmental specimens suggests that this strain may be predominant in this geographical location. These results demonstrate the usefulness of the ribotyping method for epidemiological studies of P. pseudomalki.
Pseudomonas pseudomallei is a gram-negative, saprophytic bacillus found in soil and water in the tropics (6, 7) . This bacterium is a common cause of opportunistic infections in areas of endemicity (15) . Individuals particularly susceptible to infection include diabetics and those with renal disease (1) . There is also a seasonal variation in occurrence of infections. The severity and manifestations of P. pseudomallei infections (melioidosis) are extremely variable, giving rise to acute or chronic pneumonias, abscess formation in multiple organs, and sepsis (15) . Latent infections have been reported, with development of symptoms months to years following exposure to the organism (11) . P. pseudomallei sepsis often has a fatal outcome despite treatment (1) . The organism displays high resistance to antibiotics (7) , and treatment periods of up to 9 months may be required to clear the infection (17) . Even following prolonged treatment periods, relapse is common. At present it is not known whether such relapses are due to reinfection or to recurrence of the original infection. Development of an epidemiological typing system would answer many of the questions about the source of infection, course of disease, and transmission modes of P. pseudomallei.
In this study, a total of 86 P. pseudomallei isolates of clinical and environmental origin were examined for chromosomal fragment heterogeneity by using EcoRI restriction with rRNA from Escherichia coli as a probe. This method of ribotyping was developed by Stull et al. (16) and has been used to study P. cepacia infection outbreaks in hospitals and to monitor possible transmission of P. cepacia among patients with cystic fibrosis (9) .
In the present study, isolates with the main ribotype were subtyped by using three additional restriction enzymes, HindIII, Sall, and PstI. Results of the study indicate the prevalence of one particular ribotype among clinical isolates * Corresponding author. and the apparent maintenance of one strain in individual patients during the course of their infection. In two patients who were described clinically as having "early relapse of disease," the same ribotype of P. pseudomallei was associated with both disease episodes. The ribotype was conserved in sequential isolates from patients during antibiotic therapy, although the antibiotic resistance patterns of the isolates changed. Thus, ribotype appears to be a stable marker of P. pseudomallei strains and a useful epidemiological tool. pseudomallei during the course of infection. This was true even for patients from whom bacteria were isolated from multiple sites (e.g., patients 6, 9, 20, 24, 32, 33, and 34). Two ribotypes of P. pseudomallei were isolated from patient 31, one each from sputum and urine. Patient 26 was infected with P. pseudomallei following a road traffic accident. The strain recovered from the blood of this patient (strain 813a) and the isolate believed to have been the origin of the infection (strain E139) were both found to be type A. However, on subtyping, the isolate from the patient was classed as ribotype A5 whereas the isolate believed to have been the environmental source of infection was of ribotype Al (Tables 1 and 2 ).
MATERIALS
Association of ribotype and antibiotic resistance patterns.
Treatment of melioidosis patients with the broad-spectrum cephalosporin ceftazidime has reduced the mortality rate by half (18) . A problem with such therapy has been the isolation of resistant organisms during the course of antibiotic administration (2) . In seven individual patients, a series of P. pseudomallei isolates, at least one of which was resistant to ceftazidime, were studied over the course of acute infection. The antibiotic resistance patterns of these isolates varied during the course of antibiotic therapy (Table 3 ). However, the ribotype was stably maintained in all cases, suggesting that a single strain was present throughout therapy.
Ribotype and relapse of disease. In two of the patients studied (patients 16 and 30), early clinical relapse of disease occurred (dates of isolation of P. pseudomallei are given in Table 1 ). In both cases, relapse was associated with the same ribotype that caused the original infection. This suggests that relapse of disease may be due to resurgence of the original infection rather than to reinfection. Patient 16 was harboring P. pseudomallei of the most common ribotype, Al; therefore it is difficult to attach significance to this finding since Al is such a common ribotype among the patients studied. However, the evidence is more convincing for patient 30, whose original infection and relapse were both associated with the less common ribotype D.
Association of ribotype with survival and with disease manifestations in melioidosis patients. Of the 34 patients included in this study, 15 survived, 14 died, and records of the remaining 5 were not available (Table 1 ). There was no apparent association between ribotype and survival or between ribotype and the manifestations of disease (e.g., pneumonia versus septicemia). DISCUSSION There is a clear need for a reliable epidemiological typing scheme for P. pseudomallei. It would be particularly helpful to be able to distinguish between recurrence of infection and reinfection. This information would be useful in designing treatment regimens, since infected individuals are now treated with antibiotics for up to 9 months (17). Even after such treatment periods, recurrence of disease is common. Since the immune status of these individuals is often questionable, it is possible that reinfection is a common phenomenon. However, because the pathogenesis of P. pseudomalei infection has not been clearly established, persistence of the organism during antibiotic treatment remains a plausible explanation for recurrence of disease. The variable latency of P. pseudomallei infection demonstrates the ability of the bacterium to survive in a host for prolonged periods (11) . Whether organisms in this latent state are less susceptible to antibiotic killing remains unknown.
Typing methods commonly used for bacteria include antimicrobial susceptibility (13) , bacteriocin production or sensitivity (5) , bacteriophage susceptibility (20) , and serotyping (3). Each of these methods has its limitations, since expression of each of these properties may vary depending on the stress on the bacteria or the acquisition of plasmids. c Patient from whom the isolate was believed to be the source of infection was available.
Development of methods that take advantage of the restriction fragment heterogeneity of chromosomal DNA has been useful in epidemiological studies. Both chromosomal DNA fragments (12) and rRNA (8, 14, 16) (12) demonstrated that restriction patterns were stably expressed in P. aeruginosa after multiple passages when stored under various conditions, following In this study, we were able to distinguish 10 distinct ribotypes or subtypes from clinical and environmental isolates by using ribotyping ( (10) . Since the number of environmental isolates examined was small, we cannot comment on the regional prevalence of P. pseudomallei types in this study.
For the one patient who acquired melioidosis following a traffic accident, when the apparent infecting environmental strain from his bicycle and the strain isolated from his blood were available, differences in the isolates at a subtyping level were evident. Assuming that the infecting strain was indeed isolated, the change in subtype may have occurred as a result of genetic rearrangement within the bacterium following infection. This phenomenon has been found in rats with chronic experimental P. aeruginosa pneumonia (19) .
In all but 1 of the 34 patients studied, a single ribotype was 
